Next Article in Journal
Artificial Intelligence in Differential Diagnostics of Meningitis: A Nationwide Study
Next Article in Special Issue
Electromyography-Guided Adjustment of an Occlusal Appliance: Effect on Pain Perceptions Related with Temporomandibular Disorders. A Controlled Clinical Study
Previous Article in Journal
Point Mutation Specific Antibodies in B-Cell and T-Cell Lymphomas and Leukemias: Targeting IDH2, KRAS, BRAF and Other Biomarkers RHOA, IRF8, MYD88, ID3, NRAS, SF3B1 and EZH2
Previous Article in Special Issue
Electromyographic Patterns of Masticatory Muscles in Relation to Active Myofascial Trigger Points of the Upper Trapezius and Temporomandibular Disorders
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Proteomic Expression Profile in Human Temporomandibular Joint Dysfunction

by
Andrea Duarte Doetzer
1,*,
Roberto Hirochi Herai
1,
Marília Afonso Rabelo Buzalaf
2 and
Paula Cristina Trevilatto
1
1
Graduate Program in Health Sciences, School of Medicine, Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba 80215-901, Brazil
2
Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo, Bauru 17012-901, Brazil
*
Author to whom correspondence should be addressed.
Diagnostics 2021, 11(4), 601; https://doi.org/10.3390/diagnostics11040601
Submission received: 28 February 2021 / Revised: 18 March 2021 / Accepted: 24 March 2021 / Published: 28 March 2021
(This article belongs to the Special Issue Temporomandibular Joint Diseases: Diagnosis and Management)

Abstract

:
Temporomandibular joint dysfunction (TMD) is a multifactorial condition that impairs human’s health and quality of life. Its etiology is still a challenge due to its complex development and the great number of different conditions it comprises. One of the most common forms of TMD is anterior disc displacement without reduction (DDWoR) and other TMDs with distinct origins are condylar hyperplasia (CH) and mandibular dislocation (MD). Thus, the aim of this study is to identify the protein expression profile of synovial fluid and the temporomandibular joint disc of patients diagnosed with DDWoR, CH and MD. Synovial fluid and a fraction of the temporomandibular joint disc were collected from nine patients diagnosed with DDWoR (n = 3), CH (n = 4) and MD (n = 2). Samples were subjected to label-free nLC-MS/MS for proteomic data extraction, and then bioinformatics analysis were conducted for protein identification and functional annotation. The three TMD conditions showed different protein expression profiles, and novel proteins were identified in both synovial fluid and disc sample. TMD is a complex condition and the identification of the proteins expressed in the three different types of TMD may contribute to a better comprehension of how each pathology develops and evolutes, benefitting the patient with a focus–target treatment.

1. Introduction

Temporomandibular dysfunction (TMD) is a disorder of the masticatory system and it is characterized by pain, loss of function of one or both articulations, and impairment of the masticatory system. TMD impacts not only jaw function, but the life quality of affected patients, increasing their treatment costs and work absence [1]. According to the National Institute of Health [2], TMD management in the USA costs approximately 4 billion dollars per year. A diagnostic protocol developed for research named Research Diagnostic Criteria for TMD (RDC/TMD), classifies TMD as myalgia, arthralgia, condylar pathologies, disc displacement, osteoarthrosis, osteoarthritis, degenerative joint disease and subluxation [3]. TMD has a multifactorial etiology, the most common being trauma, psychological alterations, hormone, inflammatory diseases, parafunction, and genetics [1,4]. TMD usually requires a panorex, and depending on the TMD type, magnetic resonance imaging, scintigraphy and tomography, besides a thorough clinical evaluation [5,6].
Depending on the TMD type, it can be classified as condylar hyperplasia (CH), disc displacement without reduction (DDWoR) and mandibular dislocation (MD). DDWoR is the most common TMD disorder [7], and along with CH, its etiology’s understanding is still unclear. MD is a condition that is probably caused by physical alterations [8], and since it is less likely to have hormone contribution, it is a good TMD condition to compare the results with the other pathologies. DDWoR is caused by an abnormal positional association between the disc and the condyle, where the disc is permanently anteriorly displaced in relation to the condyle, causing limited range of mouth opening, pain and may lead to temporomandibular joint (TMJ) degeneration [9]. Disc displacement corresponds to 41% of TMD intra-articular disorders [7], and it is considered a multifactorial disease, with overlapping conditions contributing to its modulation including stress, parafunction, behavioral pattern, emotional status, and genetic background [3]. Among its different types of treatment, clinical handling is firstly employed (splint therapy, medication, physiotherapy) and when unsuccessful, surgery is indicated [6,10]. MD is an involuntary forward movement of the condyle beyond the articular eminence, mostly associated with trauma or excessive mouth opening, impairing its essential functions (speaking, chewing), and it accounts for 3% of all documented dislocations [11]. It usually needs mechanical manipulation to return to its normal position, and recurrent dislocations require surgical treatment [8]. Between these TMD types, CH is the rarest pathology that manifests a head condyle overgrowth, causing facial asymmetry, deformity, malocclusion and sometimes pain and dysfunction [12]. It is a self-limiting condition, more prevalent in female teenagers, but it usually requires surgical treatment to limit facial asymmetry progression and condyle continuous elongation [13]. Studies suggest it has a genetic involvement on its development, but its main etiology is still poorly understood [14].
Despite the etiological differences between CH, DDWoR and MD, current studies have limited understanding of the molecular variations that differentiates these TMD diseases. Condylar hyperplasia, mandibular dislocation and disc displacement have been the aim of many studies, due to their difficulty in targeting the proper treatment to each disease [9]. The employment of specific treatment, which may be improved with the unveiling of its specific etiology factors, will allow us to diminish treatment time and costs.
At the proteomic level, current studies focus only on individual mandibular dysfunctions, without comparing different TMD types to show the proteomic variability that could drive novel biomarkers as targets for disease diagnostic and treatment [15,16]. Proteomic analysis is a gold standard approach to analyze all identifiable proteins in a certain tissue, investigating its abundance, variety of proteoforms, and their stable or transient protein–protein interactions. This approach is especially beneficial in the clinical setting when studying proteins involved in different pathologies [17]. To date, there are very few studies investigating human TMD samples through proteomic output, and these studies analyzed only synovial fluid, focusing on specific target proteins [15,16]. Therefore, analyzing all proteins present in the synovial fluid and disc sample of different types of TMD may potentially lead TMD treatments towards a new reality.
In this research, a high throughput proteomic investigation of the three TMD pathologies CH, DDWoR and MD, was performed. Using state-of-the-art sample extraction procedures, biological samples of synovial fluid and TMJ discs were collected from distinct patients diagnosed with these conditions. The samples were processed, subjected to protein extraction and mass spectrometry proteomic identification. Generated proteomic data were analyzed using bioinformatics methods, and a per-sample protein identification and annotation were performed. The clinical phenotypes were then used to correlate the proteomic profile of each TMD condition.

2. Materials and Methods

2.1. Sample Selection

The sample was composed of 9 disc and synovial fluid specimens from female patients, with a mean age of 31.22 years (18–52). The patients presented different TMJ conditions, with three samples being composed of TMJ displaced disc without reduction (n = 3), two mandibular dislocation (n = 2) and four patients with condylar hyperplasia (n = 4) (Table 1). The specimens were collected from patients treated at the Evangelic University Hospital of Curitiba, Brazil. The study was approved by the Ethical Committee on Research at Pontifical Catholic University of Paraná, Brazil, according to Resolution 196/96 of the National Health Council and approved on 6 May of 2016 under registration number 1.863.521.
Subjects did not present any of the following criteria: use of orthodontic appliances; chronic usage of anti-inflammatory drugs; history of diabetes, hepatitis, HIV infection; immunosuppressive chemotherapy; history of any disease known to compromise immune function; pregnancy or lactation; major jaw trauma; previous TMJ surgery; and previous steroid injection in the TMJ.
Subjects answered a personal medical history questionnaire and signed a consent form after being advised of the nature of the study. All patients were clinically examined by one experienced oral and maxillofacial surgeon. The clinical examination consisted of palpating the TMJ region, analyzing the occurrence of painful or limitation/excessiveness of mouth opening/closing, and the observation of facial asymmetry. Regarding complementary exams, all patients had a panorex and patients with disc displacement were submitted to a magnetic resonance image. The patients who were considered to be affected with disc displacement were treated surgically when they presented painful clinical signs of disc displacement after unsuccessful non-surgical treatment for at least 6 months [18]. Patients presenting pain related only to muscular spasms were not included in this research. Patients with condylar hyperplasia were diagnosed through clinical evaluation, panorex and when presenting a positive condylar growth in scintilography, a high condylectomy was indicated and performed [19]. Patients with recidivist mandibular dislocation (more than four episodes in six months) were treated with eminectomy [8].

2.2. Sample Acquisition

During access to the TMJ to perform the needed surgery [20], a 21-gauge needle was inserted into the upper TMJ space, then 1 mL of saline was injected into the joint space, which was aspirated thereafter by a second adapted syringe. This procedure was repeated five times to obtain a synovial fluid sample as described previously by Alstergren [21]. For each type of surgery performed, TMJ disc recontouring and repositioning was needed [16], therefore, first the displaced disc was freed, repositioned and sutured to the latero-posterior side of the condyle with a Mitek bone-cleat. The suture was then placed between the posterior and intermediate bands, and recontouring the thickened disk with a scalpel was necessary (this posterior debrided cartilage constituted the disc sample). Synovial fluid was spun down at 300× g to remove debris, and stored at −80°C until use or analysis, and the disc samples rinsed in phosphate-buffered saline (PBS), and either snap frozen in liquid nitrogen and stored at −80°C.

2.3. Proteomic Analysis

The microcentrifuge tubes containing the synovial fluid and TMJ discs were removed from the −80 ° C freezer, and after defrosting, the discs were cut into small pieces with the aid of sterile scissors, centrifuged, and the supernatants were collected and pooled according to each pathology group. The preparation of the samples for proteomic analysis was carried out as previously reported [22]. The analysis of the tryptic peptides was performed in the nanoACQUITY UPLC system (Waters, Milliford, CT, USA) coupled to the Xevo Q-TOF G2 mass spectrometer (MS) (Waters, Milliford, CT, USA). For this purpose, the UPLC nanoACQUITY system was equipped with a column of type HSS T3 (Acquity UPLC HSS T3 column 75 mm × 150 mm; 1.8 µm, Waters), previously balanced with 7% of the mobile phase B (100% ACN + 0.1% formic acid). The peptides were separated through a linear gradient of 7%–85% of the mobile phase B over 70 min with a flow of 0.35 µL/min and the column temperature maintained at 45 °C. The MS was operated in positive ion mode, with a 75 min data acquisition time. The obtained data were processed using ProteinLynx GlobalServer (PLGS) version 3.03 (Waters, Milliford, CT, USA). Protein identification was obtained using the ion counting algorithm incorporated into the software. The collected data were searched in the database of the species Homo sapiens downloaded from the catalog of the UniProt [23] in September of 2020. The identified proteins for the groups DDWoR, MD, and CH of synovial fluid and TMJ disc were classified and attributed by biological function, origin, and molecular interaction with the program Genemania [24]. The overlapping proteins between the groups were clustered by using an automatic Venn diagram generator.

3. Results

In this qualitative study, our aim was to explore, for the first time, a comparative analysis of the proteomic profile of three distinct TMD diseases. Although a statistical analysis was not performed, we were able to identify and describe the function of the proteins, including overlapping proteins between the investigated samples (DDWoR, MD and CH, and between both synovial fluid and disc samples).
In the synovial fluid samples, a total of 225 proteins (351 counting the repeated proteins in all groups) were successfully identified: 190 in the group DDWoR, 154 in the group MD and seven in the group CH. We also compared these three groups to identify shared or condition-specific proteins. We found 114 shared proteins between groups DDWoR and MD, and six proteins were shared by all groups (Table 2).
In the disc sample, 379 proteins were identified (697 counting the repeated proteins in all groups), with 235 proteins in group DDWoR, 196 in group MD and 266 in group CH. These three groups were also compared to identify shared or condition-specific proteins. There were nine shared proteins between groups DDWoR and MD, 28 shared proteins between groups DDWoR and CH, 17 shared proteins between groups MD and CH, and 132 shared proteins by all groups (Table 3).
Regarding the proteins in common in both synovial fluid and disc in the same sample groups, DDWoR presented two common proteins, MD presented three proteins, group CH had no protein in common, and the three groups together had six proteins in common (Table 4).
All synovial fluid and disc samples presented proteins involved in DNA repair, muscle and neural regeneration.
A selective pool of proteins was chosen to be studied according to the pathology group and protein function for synovial fluid and disc sample (Table 5 and Table 6).
The synovial fluid sample presented the following proteins functions for each group (Table 5): the DDWoR group presented proteins involved in inflammatory process, apoptosis, hearing, interleukine-6 cascade, and protection against oxidative stress; the MD group showed proteins involved in inflammatory process, apoptosis, hearing, interleukine-6 cascade, protection against oxidative stress, and immune response; in the CH group, the expression of alcohol degradation protein (ADH1) was identified. The group comprising the pathologies DDWoR and MD were mainly involved in inflammatory process inhibition, bone resorption, chondrogenesis, bone and cartilage formation, osteoarthrosis, and neuropathic pain. No proteins were observed in the groups DDWoR and CH, and MD and CH. The proteins expressed in all three groups (DDWoR, MD and CH) were mainly implicated with muscle regeneration.
The disc sample presented the following protein functions for each group (Table 6): the DDWoR group expressed proteins involved in inflammatory process, neurogenesis, cartilage formation, extracellular matrix degradation, oxidative stress and apoptosis. The MD group presented proteins related to apoptosis, vascular growth, inflammatory inhibitors, immunologic factors and epithelial growth, and the CH group showed protein expression implicated in apoptosis, apoptosis inhibition, oxidative stress, bone formation, chondroitin, bone and cartilage formation. The group with DDWoR and MD samples had proteins involved in inflammatory process; the group with DDWoR and CH samples showed proteins with collagen formation and wound healing functions; the group with MD and CH was involved in wound healing; and the group containing DDWoR, MD and CH samples was involved with inflammatory cascade modulation, osteoclastogenesis, chondrogenesis, apoptosis, bone formation, vascular and tissue repair, antioxidative activity.
There were proteins identified in both synovial fluid and TMJ disc samples, however, some of them in different pathology groups (Table 7).
Different types of collagen were identified in discs of the MD group, CH group, DDWoR and CH group, and in the group with all pathologies together (DDWoR, MD and CH). Besides the known collagen type I present in TMJ discs, collagen type IV, VI, XII and XIV were also identified (Table 8).
All shared and group-specific proteins are indicated in a Venn diagram for the synovial fluid (Figure 1) and disc samples (Figure 2).
The interactions between the proteins were analyzed with Genemania (https://genemania.org—accessed on 5 September 2020), and its genetic network pointed out distinct protein cascades that might be modulating each pathology through the synovial fluid and disc samples. The physical and genetic interactions, co-expression and pathway of the proteins are shown in Figure 3 and Figure 4.
The main proteins with important functions and networks that were identified in the synovial fluid sample were analyzed for each group (Figure 3). A brief description of these findings are: in the DDWoR group (Figure 3A) alpha-2-macroglobulin (A2M) involved in inflammatory process, amyloid P component (APCS) involved with apoptosis and complement factor H (CFH) that modulates inflammatory cascade were highlighted in the Genemania interaction figure; in the MD group (Figure 3B), hemopexin (HPX) involved in protection against oxidative stress was present; in the CH group (Figure 3C), alcohol dehydrogenase subunit alpha (ADH1) that is responsible for alcohol degradation and interacts with growth hormone receptor (GHR) was present. In the group of DDWoR and MD (Figure 3D), annexin A1 (ANXA1), decorin (DCN), and immunoglobulin heavy constant gamma 1 (IGHG1) involved in inflammatory process, annexin A2 (ANXA2) involved with bone resorption, asporin (ASPN), biglycan (BGN), cartilage intermediate layer protein (CILP), osteoglycin (OGN), transforming growth factor beta induced (TGFBI) involved in bone and cartilage formation, fibronectin 1 (FN1), lumican (LUM) and tenascin XB (TNXB) involved in tissue repair, and neurofilament medium (NEFM) and thrombospondin 4 (THBS4) involved in neuropathic pain were included in the net. The DDWoR and CH group, and MD and CH group had no protein to be analyzed. The group with the three pathologies (DDWoR, MD and CH) showed an interaction of enolase 2 (ENO2) and 3 (ENO3), involved in muscle regeneration (Figure 3E).
The disc sample presented the following protein interactions in Genemania (Figure 4): group DDWoR (Figure 4A) presented mainly the matrix metalloproteinase protein (MMP) family (1,2,3,6,8,10,13,15,16), integrin subunit alpha 6 (ITGA6) and phospholipase A2 group VII (PLA2G7) that are involved in inflammatory cascade. Additionally, thrombospondin 3 (THBS3) and 4 (THBS4) involved in tissue remodeling, and THADA armadillo repeat containing (THADA) involved in apoptosis were present. In the MD group (Figure 4B), A-kinase anchor protein 13 (AKAP13), Erbin (ERBIN) and uroplakin-3a (UPK3A) involved in apoptosis, collagen alpha-1(IV) chain (COL4A1) and GTPase Eras (ERAS) involved in disc matrix constitution, and liprin-alpha-1 (PPFIA1) and (PPFIA2) 2 responsible for cell interactions were identified in the Genemania network. In the CH group (Figure 4C), the present proteins were ADAM metallopeptidase domain 10 (ADAM10), that regulates apoptosis, collagen type I alpha 2 chain (COL1A2) and serpin family H member 1 (SERPINH1) involved in collagen formation, actinin alpha 4 (ACTN4), PDZ Additionally, LIM domain 4 (PDLIM4), transthyretin (TTR) and protein tyrosine phosphatase non-receptor type 13 (PTPN13) involved in apoptosis, hormone modulation and bone formation. In the group of DDWoR and MD (Figure 4D), the complement C4A (C4A) and complement C4B (C4B) proteins that mediates the inflammatory process were identified. In the DDWoR and CH group (Figure 4E), mainly the proteins aggrecan (ACAN), collagen type I alpha 1 chain (COL1A1) and collagen type IV alpha 6 chain (COL4A6) that constitutes disc matrix, and periostin (POSTN) involved in wound healing were identified. In the MD and CH group (Figure 4F), keratin 6A (KRT6A) involved in wound healing was identified. Additionally, in the group with all three pathologies (DDWoR, MD and CH) the proteins that interacted were annexin A1 (ANXA1), complement C3 (C3) and tenascin C (TNC) involved in inflammatory cascade modulation, annexin A2 (ANXA2) and transforming growth factor beta induced (TGFBI) involved in osteoclastogenesis, asporin (ASPN), biglycan (BGN), collagen type VI alpha 1 chain (COL6A1), osteoglycin (OGN) and vimentin (VIM) involved in chondrogenesis and osteogenesis, amyloid P component (APCS) and complement C3 (C3) in apoptosis and lumican (LUM) involved in tissue repair (Figure 4G).

4. Discussion

The different types of TMD may jeopardize patients’ quality of life, masticatory function and have a great impact on health expenses. The identification of its multifactorial etiological components will enhance the employment of specific treatments, diminishing the hazard it causes in the TMJ. Therefore, the identification of the proteins expressed on each pathology group of this study (DDWoR, MD, and CH) might elucidate the cascades involved in the progression and severity of each TMD, leading to an assertive handling of TMD.
A total of 225 proteins were identified in the synovial fluid sample, and 379 in the TMJ disc sample (Table 2). It is important to highlight that the synovial fluid sample is very complex to obtain, therefore some proteins might not have been identified due to the technique that advocates the dilution of the synovial fluid. Nevertheless, the sample was collected according to worldwide employed standard methods previously described by other research groups [21,25]. Additionally, even though few proteins’ expression might not have been observed, the expression of new proteins were identified for each pathology group, which enriches the global analysis of this study.
In our analysis, we found that all proteins expressed in the DDWoR group (synovial fluid and disc sample) (Table 2 and Table 3) presented many proteins related to inflammatory process (MMP-3, -10, -27 in the disc sample) and apoptosis (mitogen-activated protein kinase 7—MAP3K7) and THADA in synovial fluid). Only the MMP-3 protein was previously associated with TMD [26,27]. These are proteins that highly impact the degeneration process in the TMJ of patients with DDWoR [26,28]. In the MD group, ERBIN protein was found in the disc sample, and it modulates TGFB, which was previously associated with TMJ degeneration [29]. Additionally, unprecedented proteins were seen in the synovial fluid associated with apoptosis (aldehyde dehydrogenase 1 family member L—ALDH1L1) and protection against oxidative stress (HPX), which probably helps diminish the mechanical overload consequences of the dislocation in the TMJ. Regarding CH proteins in the synovial fluid sample, ADH1 catalyzes the oxidation of alcohols to aldehydes, but as seen in Genemania (Figure 3C), it interacts with GHR, which might be involved with the condylar overgrowth. In a previous study, GHR has been injected in rabbits’ TMJ to increase cartilage thickness [30], but it has not been studied as a possible etiology of condylar overgrowth yet.
Additionally, we also found a set of proteins to be common in both synovial fluid and disc samples (Table 4) in the groups DDWoR (chromodomain-helicase-DNA-binding protein 8 and myosin light chain 6B), MD (filamin A and liprin-alpha-1), and in the three groups (enolase 1, 2, 3, myosin heavy chain 16, ribosomal protein L7 like 1 and component of the shield in complex). These proteins were involved in cell matrix adhesion, cellular motor protein, reorganization of cytoskeleton, muscle development and regeneration. Additionally, another group of proteins were identified in both synovial fluid and disc samples (Table 7), being prevalent in all groups of disc samples. In the DDWoR and MD groups of synovial fluid samples, proteins implicated in apoptosis, inflammatory process, bone formation and resorption, chondrogenesis, wound healing, tissue repair and protection against oxidative stress were found. CH disc samples and MD synovial fluid samples presented, as common proteins, HPX (protection against oxidative stress) and SERPINC1 (biosynthetic pathway of collagen).
LUM is associated with the regulation of collagen fibers and with cell migration. In this study, LUM was present in all disc samples, and it has been pointed out to be elevated when the disc is under stress, as it enhances tissue repair [31]. Ulmner [32] reported that higher levels of LUM in synovial tissue might diminish TMD surgical success. On the other hand, TNC was present in all disc samples and in DDWoR and MD synovial fluid sample, being an important protein in wound healing [33].
Temporomandibular joint discs are fibrocartilaginous discs composed mainly by collagen, glycosaminoglycan and proteoglycans [34]. Studies in human adults and fetuses showed the expression of mainly collagen type I and III in TMJ discs, with type I collagen observed in the posterior band of the articular disc and collagen type III on the inferior surface of the articular disc [35,36]. Moreover, collagen type II synthesis was expressed on the external layer of the TMJ disc [37]. In this study, collagen type IV was identified in MD and CH samples (Table 8), and a previous study observed the presence of collagen type IV in the middle part of fetuses’ TMJ disc, indicating the development of blood vessels [38]. The TMJ disc is an avascular tissue, although under stress it may undergo metaplasia, forming a vascularized fibrous tissue. Collagen type VII was present in all samples, and along with collagen type IV, it has chondroprotective effects against inflammation [39]. Collagen type XII and XIV were present in the disc samples of this study, which have never been identified in this region before in humans. A study identified collagen type XII only in bovine disc samples, which helps maintain collagen type I integrity [40]. Nevertheless, collagen type XIV was also observed in all TMJ disc samples, and it plays an essential structural role in the integrity of collagen type I, mechanical properties, organization, and shape of articular cartilage, which has never been described in the TMJ disc before [41]. This is important information to understand the composition’s strength and weakness of the TMJ disc.

5. Conclusions

In conclusion, many proteins were identified for the first time in the TMJ disc and synovial fluid of the groups DDWoR, MD and CH, leading to the enlightenment of each pathology’s etiology, modulation and progression. Further studies with a greater sample are necessary to evaluate other proteins that might be present in these pathologies as well.

Author Contributions

Conceptualization: A.D.D., P.C.T., R.H.H.; methodology: A.D.D., P.C.T., R.H.H., M.A.R.B.; software: A.D.D., R.H.H., M.A.R.B.; validation: A.D.D., P.C.T., R.H.H., M.A.R.B.; formal Analysis: A.D.D., P.C.T., R.H.H., M.A.R.B.; investigation: A.D.D., P.C.T., R.H.H., M.A.R.B.; resources: A.D.D., P.C.T., R.H.H.; data curation: A.D.D., P.C.T., R.H.H., M.A.R.B.; writing—original draft preparation A.D.D., R.H.H.; writing—review and editing: A.D.D., P.C.T., R.H.H., M.A.R.B.; supervision: P.C.T., R.H.H., M.A.R.B.; project administration: A.D.D.; funding acquisition: A.D.D., P.C.T., R.H.H. All authors have read and agreed to the published version of the manuscript.

Funding

P.C.T. is supported by the National Council for Scientific and Technological Development, Chamada MCTIC/CNPq Nº 28/2018—Universal, Process: 426505/2018-2 for this research. R.H.H. is supported by Fundação Araucária (grant FA#09/2016).

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committee of Pontifical Catholic University of Paraná, Brazil, according to Resolution 196/96 of the National Health Council and approved under registration number 1.863.521, on the 20 May 2016.

Informed Consent Statement

Written informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Data is contained within the article.

Acknowledgments

We thank all individuals that were volunteers for agreeing to participate in this study. A.D.D. was supported by Fundação Araucária scholarship. P.C.T. is supported by the National Council for Scientific and Technological Development, Chamada MCTIC/CNPq Nº 28/2018—Universal, Process: 426505/2018-2 for this research. R.H.H. is supported by Fundação Araucária (grant FA#09/2016). We thank Alexandra Senegaglia and Paulo R. S. Brofman for the laboratory support at Pontifícia Universidade Católica do Paraná, Brazil.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Slade, G.D.; Ohrbach, R.; Greenspan, J.D.; Fillingim, R.B.; Bair, E.; Sanders, A.E.; Dubner, R.; Diatchenko, L.; Meloto, C.B.; Smith, S.; et al. Painful Temporomandibular Disorder: Decade of Discovery from OPPERA Studies. J. Dent. Res. 2016, 95, 1084–1092. [Google Scholar] [CrossRef] [Green Version]
  2. National Institute of Health. Available online: https://www.nidcr.nih.gov/health-info/tmj (accessed on 3 October 2019).
  3. Ohrbach, R.; Dworkin, S.F. The Evolution of TMD Diagnosis: Past, Present, Future. J. Dent. Res. 2016, 95, 1093–1101. [Google Scholar] [CrossRef] [Green Version]
  4. Minervini, G.; Lucchese, A.; Perillo, L.; Serpico, R.; Minervini, G. Unilateral superior condylar neck fracture with disloca-tion in a child treated with an acrylic splint in the upper arch for functional repositioning of the mandible. Case Rep. Cranio 2017, 35, 337–341. [Google Scholar]
  5. Eberhard, D.; Bantleon, H.; Steger, W. The efficacy of anterior repositioning splint therapy studied by magnetic resonance imaging. Eur. J. Orthod. 2002, 24, 343–352. [Google Scholar] [CrossRef]
  6. Supplement, D.; Minervini, G.; Nucci, L.; Lanza, A.; Femiano, F.; Contaldo, M.; Grassia, V. Temporomandibular disc displacement with reduction treated with anterior repositioning splint: A 2-year clinical and magnetic resonance imaging (MRI) follow-up. Case Rep. J. Biol. Regul. Homeost. Agents 2020, 34, 151–160. [Google Scholar]
  7. Talaat, W.M.; Adel, O.I.; Al Bayatti, S. Prevalence of temporomandibular disorders discovered incidentally during routine dental examination using the Research Diagnostic Criteria for Temporomandibular Disorders. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2018, 125, 250–259. [Google Scholar] [CrossRef] [PubMed]
  8. Cakarer, S.; Isler, S.; Yalcin, B.; Şitilci, T. Management of the bilateral chronic temporomandibular joint dislocation. Ann. Maxillofac. Surg. 2018, 8, 154. [Google Scholar] [CrossRef] [PubMed]
  9. Poluha, R.L.; Canales, G.D.L.T.; Costa, Y.M.; Grossmann, E.; Bonjardim, L.R.; Conti, P.C.R. Temporomandibular joint disc displacement with reduction: A review of mechanisms and clinical presentation. J. Appl. Oral Sci. 2019, 27, e20180433. [Google Scholar] [CrossRef]
  10. Fayed, M.M.S.; El-Mangoury, N.H.; El-Bokle, D.N.; Belal, I.A. Occlusal splint therapy and magnetic resonance imaging. World J. Orthod. 2004, 5, 133–140. [Google Scholar]
  11. Prechel, U.; Ottl, P.; Ahlers, O.M.; Neff, A. The Treatment of Temporomandibular Joint Dislocation: A Systematic Review. Dtsch. Arztebl. Int. 2018, 115, 59–64. [Google Scholar]
  12. Nitzan, D.W.; Katsnelson, A.; Bermanis, I.; Brin, I.; Casap, N. The clinical characteristics of condylar hyperplasia: Expe-rience with 61 patients. J. Oral Maxillofac. Surg. 2008, 66, 312–318. [Google Scholar] [CrossRef] [PubMed]
  13. Raijmakers, P.G.; Karssemakers, L.H.; Tuinzing, D.B. Female Predominance and Effect of Gender on Unilateral Condylar Hyperplasia: A Review and Meta-Analysis. J. Oral Maxillofac. Surg. 2012, 70, 72–76. [Google Scholar] [CrossRef]
  14. Mahajan, M. Unilateral condylar hyperplasia—A genetic link? Case reports. Nat. J. Maxillofacial Surg. 2017, 8, 58–63. [Google Scholar] [CrossRef] [Green Version]
  15. Herr, M.M.; Fries, K.M.; Upton, L.G.; Edsberg, L.E. Potential Biomarkers of Temporomandibular Joint Disorders. J. Oral Maxillofac. Surg. 2011, 69, 41–47. [Google Scholar] [CrossRef] [PubMed]
  16. Demerjian, G.G.; Sims, A.B.; Stack, B.C. Proteomic signature of Temporomandibular Joint Disorders (TMD): Toward di-agnostically predictive biomarkers. Bioinformation 2011, 6, 282–284. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. DuPree, E.J.; Jayathirtha, M.; Yorkey, H.; Mihasan, M.; Petre, B.A.; Darie, C.C. A Critical Review of Bottom-Up Proteomics: The Good, the Bad, and the Future of this Field. Proteomes 2020, 8, 14. [Google Scholar] [CrossRef] [PubMed]
  18. Murphy, M.K.; MacBarb, R.F.; Wong, M.E.; Athanasiou, K.A. Temporomandibular Joint Disorders: A Review of Etiology, Clinical Management, and Tissue Engineering Strategies. Int. J. Oral Maxillofac. Implant. 2013, 28, 393–414. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Olate, S.; Netto, H.D.; Rodriguez-Chessa, J.; Alister, J.P.; Albergaria-Barbosa, J.P.; de Moraes, J. Mandible condylar hy-perplasia: A review of diagnosis and treatment protocol. Int J. Clin. Exp. Med. 2013, 6, 727–737. [Google Scholar] [PubMed]
  20. Mehra, P.; Wolford, L.M. Serum nutrient deficiencies in the patient with complex temporomandibular joint problems. Bayl. Univ. Med. Cent. Proc. 2008, 21, 243–247. [Google Scholar] [CrossRef]
  21. Alstergren, P.; Benavente, C.; Kopp, S. Interleukin-1beta, interleukin-1 receptor antagonist, and interleukin-1 soluble receptor II in temporomandibular joint synovial fluid from patients with chronic polyarthritides. J. Oral Maxillofac. Surg. 2003, 61, 1171–1178. [Google Scholar] [CrossRef]
  22. Cassiano, L.P.; Ventura, T.M.; Silva, C.M.; Leite, A.L.; Magalhães, A.C.; Pessan, J.P.; Buzalaf, M.A.R. Protein Profile of the Acquired Enamel Pellicle after Rinsing with Whole Milk, Fat-Free Milk, and Water: An in vivo Study. Caries Res. 2018, 52, 288–296. [Google Scholar] [CrossRef] [Green Version]
  23. Universal Protein Resource. Available online: http://www.uniprot.org (accessed on 5 September 2020).
  24. Warde-Farley, D.; Donaldson, S.L.; Comes, O.; Zuberi, K.; Badrawi, R.; Chao, P.; Franz, M.; Grouios, C.; Kazi, F.; Lopes, C.T.; et al. The GeneMANIA prediction server: Biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010, 38, 214–220. [Google Scholar] [CrossRef]
  25. Fredriksson, L.; Alstergren, P.; Kopp, S. Tumor Necrosis Factor-α in Temporomandibular Joint Synovial Fluid Predicts Treatment Effects on Pain by Intra-Articular Glucocorticoid Treatment. Mediat. Inflamm. 2006, 2006, 59425. [Google Scholar] [CrossRef] [Green Version]
  26. Fujita, H.; Morisugi, T.; Tanaka, Y.; Kawakami, T.; Kirita, T.; Yoshimura, Y. MMP-3 activation is a hallmark indicating an early change in TMJ disorders, and is related to nitration. Int. J. Oral Maxillofac. Surg. 2009, 38, 70–78. [Google Scholar] [CrossRef]
  27. Tiilikainen, P.; Pirttiniemi, P.; Kainulainen, T.; Pernu, H.; Raustia, A. MMP-3 and -8 expression is found in the condylar surface of temporomandibular joints with internal derangement. J. Oral Pathol. Med. 2005, 34, 39–45. [Google Scholar] [CrossRef] [PubMed]
  28. Loreto, C.; Filetti, V.; Almeida, L.E.; Rosa, G.R.; Leonardi, R.; Grippaudo, C.; Giudice, A. MMP-7 and MMP-9 are over-expressed in the synovial tissue from severe temporomandibular joint dysfunction. Eur. J. Histochem. 2020, 64, 3113. [Google Scholar] [CrossRef]
  29. Da Costa, G.F.A.; Souza, R.D.C.; de Araújo, G.M.; Gurgel, B.C.V.; Barbosa, G.A.S.; Calderon, P.D.S. Does TGF-beta play a role in degenerative temporomandibular joint diseases? A systematic review. Cranio 2017, 35, 228–232. [Google Scholar] [CrossRef] [PubMed]
  30. Ulmner, M.; Sugars, R.; Naimi-Akbar, A.; Tudzarovski, N.; Kruger-Weiner, C.; Lund, B. Synovial Tissue Proteins and Patient-Specific Variables as Predictive Factors for Temporomandibular Joint Surgery. Diagnostics 2020, 11, 46. [Google Scholar] [CrossRef] [PubMed]
  31. Feizbakhsh, M.; Razavi, M.; Minaian, M.; Teimoori, F.; Dadgar, S.; Maghsoodi, S. The effect of local injection of the human growth hormone on the mandibular condyle growth in rabbit. Dent. Res. J. 2014, 11, 436–441. [Google Scholar]
  32. Koyama, E.; Saunders, C.; Salhab, I.; Decker, R.; Chen, I.; Um, H.; Pacifici, M.; Nah, H. Lubricin is Required for the Structural Integrity and Post-natal Maintenance of TMJ. J. Dent. Res. 2014, 93, 663–670. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Stocum, D.L.; Roberts, W.E. Part I: Development and Physiology of the Temporomandibular Joint. Curr. Osteoporos. Rep. 2018, 16, 360–368. [Google Scholar] [CrossRef]
  34. Berkovitz, B.K.B.; Holland, G.R.; Moxham, B.J. Oral Anatomy, Histology and Embryology, 4th ed.; Mosby: St. Louis, MD, USA, 2009. [Google Scholar]
  35. Gage, J.; Virdi, A.; Triffitt, J.; Howlett, C.; Francis, M. Presence of type III collagen in disc attachments of human temporomandibular joints. Arch. Oral Biol. 1990, 35, 283–288. [Google Scholar] [CrossRef]
  36. De Moraes, L.O.; Lodi, F.R.; Gomes, T.S.; Marques, S.R.; Oshima, C.T.; Lancellotti, C.L.; Rodríguez-Vázquez, J.F.; Mé-rida-Velasco, J.R.; Alonso, L.G. Immunohistochemical expression of types I and III collagen antibodies in the tem-poromandibular joint disc of human foetuses. Eur. J. Histochem. 2011, 55, 24. [Google Scholar] [CrossRef] [Green Version]
  37. Kondoh, T.; Hamada, Y.; Iino, M.; Takahashi, T.; Kikuchi, T.; Fujikawa, K.; Seto, K. Regional differences of type II collagen synthesis in the human temporomandibular joint disc: Immunolocalization study of carboxy-terminal type II procollagen peptide (chondrocalcin). Arch. Oral Biol. 2003, 48, 621–625. [Google Scholar] [CrossRef]
  38. De Moraes, L.O.; Lodi, F.R.; Gomes, T.S.; Marques, S.R.; Fernandes Junior, J.A.; Oshima, C.T.; Alonso, L.G. Immuno-histochemical expression of collagen type IV antibody in the articular disc of the temporomandibular joint of human fe-tuses. Ital. J. Anat. Embryol. 2008, 113, 91–95. [Google Scholar] [PubMed]
  39. Chu, W.C.; Zhang, S.; Sng, T.J.; Ong, Y.J.; Tan, W.-L.; Ang, V.Y.; Foldager, C.B.; Toh, W.S. Distribution of pericellular matrix molecules in the temporomandibular joint and their chondroprotective effects against inflammation. Int. J. Oral Sci. 2017, 9, 43–52. [Google Scholar] [CrossRef] [PubMed]
  40. Deng, M.H.; Xu, J.; Cai, H.X.; Fang, W.; Long, X. Effect of temporomandibular joint disc perforation on expression of type ? collagen in temporomandibular joint disc cells. Chin. J. Stomatol. 2017, 52, 274–277. [Google Scholar]
  41. Ciavarella, D.; Mastrovincenzo, M.; Sabatucci, A.; Campisi, G.; Di Cosola, M.; Suriano, M.; Muzio, L.L. Primary and secondary prevention procedures of temporo-mandibular joint disease in the evolutive age. Minerva Pediatr. 2009, 61, 93–97. [Google Scholar]
Figure 1. Venn diagram for synovial fluid: group 1—DDWoR, group 2—MD, group 3—CH.
Figure 1. Venn diagram for synovial fluid: group 1—DDWoR, group 2—MD, group 3—CH.
Diagnostics 11 00601 g001
Figure 2. Venn diagram for the TMJ disc: group 1—DDWoR, group 2—MD, group 3—CH.
Figure 2. Venn diagram for the TMJ disc: group 1—DDWoR, group 2—MD, group 3—CH.
Diagnostics 11 00601 g002
Figure 3. Gene interactions between the main functional proteins of synovial fluid. (A) showing the gene interactions of the DDWoR group. (B) showing the gene interactions of the MD group. (C) showing the gene interactions of the CH group. (D) showing the gene interactions of the DDWoR and MD group. (E) showing the gene interactions of the DDWoR, MD and CH group.
Figure 3. Gene interactions between the main functional proteins of synovial fluid. (A) showing the gene interactions of the DDWoR group. (B) showing the gene interactions of the MD group. (C) showing the gene interactions of the CH group. (D) showing the gene interactions of the DDWoR and MD group. (E) showing the gene interactions of the DDWoR, MD and CH group.
Diagnostics 11 00601 g003aDiagnostics 11 00601 g003b
Figure 4. Gene interactions between the main functional proteins of the TMJ disc. (A) showing the gene interactions of the DDWoR group. (B) showing the gene interactions of the MD group. (C) showing the gene interactions of the CH group. (D) showing the gene interactions of the CH group. (E) showing the gene interactions of the DDWoR and CH group. (F) showing the gene interactions of the MD and CH group. (G) showing the gene interactions of the DDWoR, MD and CH group.
Figure 4. Gene interactions between the main functional proteins of the TMJ disc. (A) showing the gene interactions of the DDWoR group. (B) showing the gene interactions of the MD group. (C) showing the gene interactions of the CH group. (D) showing the gene interactions of the CH group. (E) showing the gene interactions of the DDWoR and CH group. (F) showing the gene interactions of the MD and CH group. (G) showing the gene interactions of the DDWoR, MD and CH group.
Diagnostics 11 00601 g004aDiagnostics 11 00601 g004bDiagnostics 11 00601 g004c
Table 1. Baseline characteristics of the sample, showing age and pathology of each female patient.
Table 1. Baseline characteristics of the sample, showing age and pathology of each female patient.
NumberAgeDiagnostic
1 18 Condylar Hyperplasia
2 20 Condylar Hyperplasia
3 38 Mandibular Dislocation
4 38 Mandibular Dislocation
5 36 Condylar Hyperplasia
6 29 Condylar Hyperplasia
7 25 Disc Displacement Without Reduction
8 25 Disc Displacement Without Reduction
9 52 Disc Displacement Without Reduction
Table 2. Gene code and name of the proteins expressed in synovial fluid of all groups (disc displacement without reduction (DDWoR), mandibular dislocation (MD), condylar hyperplasia (CH) and between the groups DDWoR and MD, DDWoR and CH, MD and CH and DDWoR, MD and CH.
Table 2. Gene code and name of the proteins expressed in synovial fluid of all groups (disc displacement without reduction (DDWoR), mandibular dislocation (MD), condylar hyperplasia (CH) and between the groups DDWoR and MD, DDWoR and CH, MD and CH and DDWoR, MD and CH.
Protein Expressed in Each Group of TMJ Synovial Fluid Sample (n = 225)
DDWoR (n = 70)MD (n = 34)CH (n = 1)DDWoR and MD (n = 114)DDWoR and CH (n = 0)MD and CH (n = 0)DDWoR, MD and CH (n = 6)
CodeNameCodeNameCodeNameCodeNameXXCodeName
A2MAlpha-2-MacroglobulinACTR3BActin Related Protein 3BADH1Alcohol Dehydrogenase Subunit AlphaABI3BPABI Family Member 3 Binding Protein ENO1Enolase 1
ANXA5Annexin A5ACTR3CActin Related Protein 3C ACTA1Actin Alpha 1, Skeletal Muscle ENO2Enolase 2
APCSAmyloid P ComponentAKNAAT-Hook Transcription Factor ACTA2Actin Alpha 2, Smooth Muscle ENO3Enolase 3
APOHApolipoprotein HALDH1L1Aldehyde Dehydrogenase 1 Family Member L1 ACTBActin Beta MYH16Myosin Heavy Chain 16 Pseudogene
ARHGAP21Rho GTPase Activating Protein 21 C4AComplement C4A (Rodgers Blood Group) ACTBL2Actin Beta Like 2 RPL7L1Ribosomal Protein L7 Like 1
CFHComplement Factor HC4B_2Complement Component 4B ACTC1Actin Alpha Cardiac Muscle 1 SHLD3Shieldin Complex Subunit 3
CHD8Chromodomain Helicase DNA Binding Protein 8C7orf57Complement C7 ACTG1Actin Gamma 1
CILP2Cartilage Intermediate Layer Protein CAGE1Cancer Antigen 1 ACTG2Actin Gamma 2, Smooth Muscle
CNOT6LCCR4-NOT Transcription Complex Subunit 6 LikeCPSF2Cleavage And Polyadenylation Specific Factor 2 ALBAlbumin
DAGLADiacylglycerol Lipase AlphaDCAF4L2DDB1 And CUL4 Associated Factor 4 Like 2 ANXA1Annexin A1
DPYSL2Dihydropyrimidinase Like 2DHRS11Dehydrogenase/Reductase 11 ANXA2Annexin A2
DPYSL3Dihydropyrimidinase Like 3DMDDystrophin ANXA2P2Annexin A2 Pseudogene 2
DYMDymeclinFLNAFilamin A APOA1Apolipoprotein A1
DYNC1H1Dynein Cytoplasmic 1 Heavy ChainHPRHaptoglobin-Related Protein ASPNAsporin
ENPP3Ectonucleotide Pyrophosphatase/Phosphodiesterase 3HPXHemopexin ATP5F1BATP Synthase F1 Subunit Beta
FGFR2Fibroblast Growth Factor Receptor 2IFT122Intraflagellar Transport 122 BGNBiglycan
GPSM2G Protein Signaling Modulator 2LMO7LIM Domain 7 C3Complement C3
GPX3Glutathione Peroxidase 3MYO6Myosin VI CILPCartilage Intermediate Layer Protein
GSTP1Glutathione S-Transferase Pi 1PDIA3Protein Disulfide Isomerase Family A Member 3 CLUClusterin
H2BC1H2B Clustered Histone 1PPFIA1PTPRF Interacting Protein Alpha 1 COL12A1Collagen Type XII Alpha 1 Chain
H2BE1H2B.E Variant Histone 1 PPFIA2PTPRF Interacting Protein Alpha 2 COL14A1Collagen Type XIV Alpha 1 Chain
HSPA1AHeat Shock Protein Family A (Hsp70) Member 1APRDX1Peroxiredoxin 1 COL1A1Collagen Type I Alpha 1 Chain
HSPA1BHeat Shock Protein Family A (Hsp70) Member 1BPRDX2Peroxiredoxin 2 COL6A1Collagen Type VI Alpha 1 Chain
HSPA1LHeat Shock Protein Family A (Hsp70) Member 1 LikeRGMBRepulsive Guidance Molecule BMP Co-Receptor B COL6A2Collagen Type VI Alpha 2 Chain
HSPA2Heat Shock Protein Family A (Hsp70) Member 2SACM1LSAC1 Like Phosphatidylinositide Phosphatase COL6A3Collagen Type VI Alpha 3 Chain
HSPA8Heat Shock Protein Family A (Hsp70) Member 8SERPINA9Serpin Family A Member 9 COMPThrombospondin-5
IGLC1Immunoglobulin Lambda Constant 1SERPINH1Serpin Family H Member 1 DCNDecorin
IGLC2Immunoglobulin Lambda Constant SLC4A1Solute Carrier Family 4 Member 1 DESDesmin
IGLC3Immunoglobulin Lambda Constant 3 SMPD3Sphingomyelin Phosphodiesterase 3 DPTDermatopontin
Immunoglobulin Lambda Constant 6 Teneurin Transmembrane Protein 4 Fibrillin 1
IGLC6Immunoglobulin Lambda Constant 7 TENM4Transmembrane O-Mannosyltransferase Targeting Cadherins 3 FBN1Fibrinogen Alpha Chain
IGLC7Immunoglobulin Lambda Like Polypeptide 1TMTC3Testis Specific 10 FGAFibrinogen Beta Chain
IGLL1Immunoglobulin Lambda Like Polypeptide 5TSGA10Transthyretin FGBFibrinogen Gamma Chain
IGLL5Interferon Regulatory Factor 7 TTRUbiquitin Specific Peptidase 10 FGGFibromodulin
IRF7Kalirin RhoGEF KinaseUSP10Actin Related Protein 3B FMODFibronectin 1
KALRNKelch Repeat And BTB Domain Containing 11 FN1Glyceraldehyde-3-Phosphate Dehydrogenase
KBTBD11Keratocan GAPDHGelsolin
KERAKeratin 18 GSNH2B Clustered Histone 11
KRT18Keratin 7 H2BC11H2B Clustered Histone 12
KRT7Keratin 8 H2BC12H2B Clustered Histone 13
KRT8Keratin 84 H2BC13H2B Clustered Histone 14
KRT84Putative Uncharacterized Protein H2BC14H2B Clustered Histone 15
LOC400499Leucine Rich Repeat Containing 9 H2BC15H2B Clustered Histone 17
LRRC9Mitogen-Activated Protein Kinase Kinase Kinase 7 H2BC17H2B Clustered Histone 18
MAP3K7Microfibril Associated Protein 5 H2BC18H2B Clustered Histone 21
MFAP5Myosin Light Chain 6B H2BC21H2B Clustered Histone 3
MYL6BNCK Associated Protein 5 H2BC3H2B Clustered Histone 5
NCKAP5Nik Related Kinase H2BC5H2B Clustered Histone 9
NRKPericentriolar Material 1 H2BC9H2B.S Histone 1
PCM1Procollagen C-Endopeptidase Enhancer H2BS1H2B.U Histone 1
PCOLCERAD54 Like H2BU1Hemoglobin Subunit Alpha 1
RAD54LRetinol Dehydrogenase 5 HBA1Hemoglobin Subunit Alpha 2
RDH5Ret Proto-Oncogene HBA2Hemoglobin Subunit Beta
RETRegulatory Factor X1 HBBHemoglobin Subunit Delta
RFX1RPTOR Independent Companion Of MTOR Complex 2 HBDHemoglobin Subunit Epsilon 1
RICTORRIMS Binding Protein 3 HBE1Hemoglobin Subunit Gamma 1
RIMBP3RUN And FYVE Domain Containing 2 HBG1Hemoglobin Subunit Gamma 2
RUFY2Serpin Family C Member 1 HBG2Haptoglobin
SERPINC1Serpin Family F Member 1 HPHeat Shock Protein Family B (Small) Member 1
SERPINF1SEC14 And Spectrin Domain Containing 1 HSPB1Immunoglobulin Heavy Constant Alpha 1
SESTD1Small Nuclear Ribonucleoprotein U5 Subunit 200 IGHA1Immunoglobulin Heavy Constant Alpha 2 (A2m Marker)
SNRNP200SVOP Like IGHA2Immunoglobulin Heavy Constant Gamma 1 (G1m Marker
SVOPLTranscription Elongation Factor, Mitochondrial IGHG1Immunoglobulin Heavy Constant Gamma 2
TEFMThrombospondin 3 IGHG2Immunoglobulin Heavy Constant Gamma 3
THBS3Tenascin C IGHG3Immunoglobulin Heavy Constant Gamma 4
TNCTrio Rho Guanine Nucleotide Exchange Factor IGHG4Immunoglobulin Kappa Constant
TRIOTubulin Beta 1 Class VI IGKCInternexin Neuronal Intermediate Filament Protein Alpha
TUBB1Ubiquitin Specific Peptidase 42 INAGalectin 1
USP42WW Domain Binding Protein 1 Like LGALS1Lamin
WBP1LZinc Finger ZZ-Type And EF-Hand Domain Containing 1 LMNALumican
ZZEF1H2B Clustered Histone 1 LUMMicrofibril Associated Protein 4
MFAP4Myosin Light Chain 6
MYL6Myocilin
MYOCNeurofilament Heavy
NEFHNeurofilament Light
NEFLNeurofilament Medium
NEFMOsteoglycin
OGNPellino E3 Ubiquitin Protein Ligase Family Member 3
PELI3Pyruvate Kinase M1/2
PKMPOTE Ankyrin Domain Family Member E
POTEEPOTE Ankyrin Domain Family Member F
POTEFPOTE Ankyrin Domain Family Member I
POTEIPOTE Ankyrin Domain Family Member J
POTEJPOTE Ankyrin Domain Family Member K, Pseudogene
POTEKPPeptidylprolyl Isomerase A
PPIAProline And Arginine Rich End Leucine Rich Repeat Protein
PRELPPeripherin
PRPHS100 Calcium Binding Protein A10
S100A10Serpin Family A Member 1
SERPINA1Superoxide Dismutase 3
SOD3Transferrin
TFTransforming Growth Factor Beta Induced
TGFBIThrombospondin 4
THBS4Tenascin XA
TNXATenascin XB
TNXBTubulin Alpha 1a
TUBA1ATubulin Alpha 1b
TUBA1BTubulin Alpha 1c
TUBA1CTubulin Alpha 3c
TUBA3CTubulin Alpha 3d
TUBA3DTubulin Alpha 3e
TUBA3ETubulin Alpha 4a
TUBA4ATubulin Alpha 8
TUBA8Tubulin Beta Class I
TUBBTubulin Beta 2A Class IIa
TUBB2ATubulin Beta 2B Class IIb
TUBB2BTubulin Beta 3 Class III
TUBB3Tubulin Beta 4A Class IVa
TUBB4ATubulin Beta 4B Class IVb
TUBB4BTubulin Beta 6 Class V
TUBB6Tubulin Beta 8 Class VIII
TUBB8Tubulin Beta 8B
TUBB8BVersican
VCANVIM
VIMABI Family Member 3 Binding Protein
Table 3. Gene code and name of the proteins expressed in temporomandibular joint (TMJ) discs of all groups (DDWoR, MD, CH) and between the groups DDWoR and MD, DDWoR and CH, MD and CH and DDWoR, MD and CH.
Table 3. Gene code and name of the proteins expressed in temporomandibular joint (TMJ) discs of all groups (DDWoR, MD, CH) and between the groups DDWoR and MD, DDWoR and CH, MD and CH and DDWoR, MD and CH.
Protein Expressed in Each Group of TMJ Disc Sample (n = 379)
DDWoR
(n= 66)
MD (n = 38)CH (n = 89)DDWoR and MD (n = 9)DDWoR and CH (n = 28)MD and CH (n = 17)DDWoR, MD and CH
(n = 132)
CodeNameCodeNameCodeNameCodeNameCodeNameCodeNameCodeName
ABCC9ATP Binding Cassette Subfamily C Member 9AFTPHAftiphilinACTN1Actinin Alpha 1ATP7BATPase Copper Transporting BetaACANAggrecanATP5F1BATP Synthase F1 Subunit BetaA2MAlpha-2-Macroglobulin
ACSS3Acyl-CoA Synthetase Short Chain Family Member 3AKAP13A-kinase anchor protein 13ACTN4Actinin Alpha 4AXIN2Axin 2APOHApolipoprotein HGFAPGlial Fibrillary Acidic ProteinABI3BPABI Family Member 3 Binding Protein
AGO4Argonaute RISC Component 4ALDH3A2Aldehyde dehydrogenase family 3 member A2ACTR3Actin Related Protein 3C4AComplement C4ABRD3Bromodomain Containing 3KRT3Keratin 3ACTA1Actin Alpha 1, Skeletal Muscle
AMBPAlpha-1-Microglobulin/Bikunin PrecursorANKRD44Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit BADAM10ADAM Metallopeptidase Domain 10C4BComplement C4BCLTCClathrin Heavy ChainKRT5Keratin 5ACTA2Actin Alpha 2, Smooth Muscle
ANKRD17Ankyrin Repeat Domain 17ANKRD52Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit CADSLAdenylosuccinate LyaseC4B_2Complement Component 4BCOL1A1Collagen Type I Alpha 1 ChainKRT6AKeratin 6AACTBActin Beta
ARHGAP35Rho GTPase Activating Protein 35ARMH3Armadillo-like helical domain-containing protein 3ALDOAAldolase, Fructose-Bisphosphate AKERAKeratocanCOL4A6Collagen Type IV Alpha 6 ChainKRT6BKeratin 6BACTBL2Actin Beta Like 2
ARHGEF10Rho Guanine Nucleotide Exchange Factor 10CCDC88AGirdinALDOCAldolase, Fructose-Bisphosphate CKIAA0556Katanin Interacting ProteinDNAH8Defensin Alpha 1KRT6CKeratin 6CACTC1Actin Alpha Cardiac Muscle 1
ATAD2BATPase Family AAA Domain Containing 2BCLUHClustered mitochondria protein homologANKMY1Ankyrin Repeat And MYND Domain Containing 1MAP4Microtubule Associated Protein 4EEF1A1Dynein Axonemal Heavy Chain 8KRT75Keratin 75ACTG1Actin Gamma 1
BCAS2BCAS2 Pre-MRNA Processing FactorCOL4A1Collagen alpha-1(IV) chainANXA5Annexin A5SEMA4FSemaphorin 4FEEF1A1P5Eukaryotic Translation Elongation Factor 1 Alpha 1KRT76Keratin 76ACTG2Actin Gamma 2
CARNS1Carnosine Synthase 1DOCK10Dedicator of cytokinesis protein 10ANXA6Annexin A6 EEF1A2Eukaryotic Translation Elongation Factor 1 Alpha 1 Pseudogene 5KRT78Keratin 78ALBAlbumin
CCDC187Coiled-Coil Domain Containing 187DTHD1Death domain-containing protein 1ASXL1ASXL Transcriptional Regulator 1 HMCN2Eukaryotic Translation Elongation Factor 1 Alpha 2KRT79Keratin 79ANXA1Annexin A1
CDCP1CUB Domain Containing Protein 1ERASGTPase ERasATP2C1ATPase Secretory Pathway Ca2+ Transporting 1 HSPA2Hemicentin 2KRT81Keratin 81ANXA2Annexin A2
CDH3Cadherin 3ERBINErbinBLOC1S1Biogenesis Of Lysosomal Organelles Complex 1 Subunit 1 HSPA8Heat Shock Protein Family A (Hsp70) Member 2KRT83Keratin 83ANXA2P2Annexin A2 Pseudogene 2
CHD7Chromodomain Helicase DNA Binding Protein 7FLNAFilamin-ABRCA2BRCA2 DNA Repair Associated HYDINHeat Shock Protein Family A (Hsp70) Member 8KRT85Keratin 85APCSAmyloid P Component
CHD8Chromodomain Helicase DNA Binding Protein 8GOT1L1Putative aspartate aminotransferase, cytoplasmic 2CABP5Calcium Binding Protein 5 IGLC1HYDIN Axonemal Central Pair Apparatus ProteinKRT86Keratin 86APOA1Apolipoprotein A1
CHD9Chromodomain Helicase DNA Binding Protein 9HHLA1HERV-H LTR-associating protein 1CACNA2D3Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 3 IGLC2Immunoglobulin Lambda Constant 1PKMPyruvate Kinase M1/2ASPNAsporin
CSTF2TCleavage Stimulation Factor Subunit 2 Tau VariantIGHV3OR16–9Immunoglobulin heavy variable 3/OR16–9 (non-functional)CCDC18Coiled-Coil Domain Containing 18 IGLC3Immunoglobulin Lambda Constant 2TTBK2Tau Tubulin Kinase 2BGNBiglycan
ECH1Enoyl-CoA Hydratase 1KDF1Keratinocyte differentiation factor 1CDC20Cell Division Cycle 20 IGLC6Immunoglobulin Lambda Constant 3 C3Complement C3
ELAVL3ELAV Like RNA Binding Protein 3L1CAMNeural cell adhesion molecule L1CENPFCentromere Protein F IGLC7Immunoglobulin Lambda Constant 6 CILPCartilage Intermediate Layer Protein
EML4EMAP Like 4MARK1Serine/threonine-protein kinase MARK1CFAP20DCCFAP20 Domain Containing IGLL1Immunoglobulin Lambda Constant 7 CILP2Cartilage Intermediate Layer Protein 2
FARP2FERM, ARH/RhoGEF And Pleckstrin Domain Protein 2NEIL3Endonuclease 8-like 3CNTN1Contactin 1 IGLL5Immunoglobulin Lambda Like Polypeptide 1 CLUClusterin
FBN1Fibrillin 1NOL8Nucleolar protein 8COQ8BCoenzyme Q8B LOC441081Immunoglobulin Lambda Like Polypeptide 5 COL12A1Collagen Type XII Alpha 1 Chain
GALK2Galactokinase 2NUFIP1Nuclear fragile X mental retardation-interacting protein 1CTNNA3Catenin Alpha 3 MIS18BP1POM121 Membrane Glycoprotein (Rat) Pseudogene COL14A1Collagen Type XIV Alpha 1 Chain
GPR162G Protein-Coupled Receptor 162NUMA1Nuclear mitotic apparatus protein 1DPYSL2Dihydropyrimidinase Like 2 MYO15BMIS18 Binding Protein 1 COL6A1Collagen Type VI Alpha 1 Chain
GPRASP1G Protein-Coupled Receptor Associated Sorting Protein 1PARP10Protein mono-ADP-ribosyltransferase PARP10EHD2EH Domain Containing 2 POSTNMyosin XVB COL6A2Collagen Type VI Alpha 2 Chain
IKBKEInhibitor Of Nuclear Factor Kappa B Kinase Subunit EpsilonPCDHA4Protocadherin alpha-4EYSEyes Shut Homolog SERPINA9Periostin COL6A3Collagen Type VI Alpha 3 Chain
INSInsulinPOLD1DNA polymerase delta catalytic subunitF13A1Coagulation Factor XIII A Chain VTNSerpin Family A Member 9 COMPCartilage Oligomeric Matrix Protein
IRF2BPLInterferon Regulatory Factor 2 Binding Protein LikePOM121L2POM121-like protein 2GOLGA4Golgin A4 DCNDecorin
ITGA6Integrin Subunit Alpha 6PPFIA1Liprin-alpha-1GSTP1Glutathione S-Transferase Pi 1 DESDesmin
KRT26Keratin 26PPFIA2Liprin-alpha-2GVINP1GTPase, Very Large Interferon Inducible Pseudogene 1 DMDDystrophin
LEMD2LEM Domain Nuclear Envelope Protein 2PRR14LProtein PRR14LH3-2H3.2 Histone (Putative) DPTDermatopontin
MAP3K21Mitogen-Activated Protein Kinase Kinase Kinase 21PTPN7Tyrosine-protein phosphatase non-receptor type 7H3-3AH3.3 Histone A ENO1Enolase 1
MDGA1MAM Domain Containing Glycosylphosphatidylinositol Anchor 1RASSF10Ras association domain-containing protein 10H3-3BH3.3 Histone B ENO2Enolase 2
MMP10Matrix Metallopeptidase 10RPS6KA6Ribosomal protein S6 kinase alpha-6H3-4H3.4 Histone ENO3Enolase 3
MMP27Matrix Metallopeptidase 27TRIOTRIO and F-actin-binding proteinH3-5H3.5 Histone FBLN1Fibulin 1
MMP3Matrix Metallopeptidase 3TSC1HamartinHEATR6HEAT Repeat Containing 6 FGAFibrinogen Alpha Chain
MOSMOS Proto-Oncogene, Serine/Threonine KinasUPK3AUroplakin-3aHPXHemopexin FGBFibrinogen Beta Chain
MYL6Myosin Light Chain 6URODUroporphyrinogen decarboxylaseHSP90B1Heat Shock Protein 90 Beta Family Member 1 FGGFibrinogen Gamma Chain
MYO7BMyosin VIIB HSPA1AHeat Shock Protein Family A (Hsp70) Member 1A FLNBFilamin B
NT5E5’-Nucleotidase Ecto HSPA1BHeat Shock Protein Family A (Hsp70) Member 1B FMODFibromodulin
OLFML1Olfactomedin Like 1 HSPA1LHeat Shock Protein Family A (Hsp70) Member 1 Like FN1Fibronectin 1
PGM5Phosphoglucomutase 5 HSPA5Heat Shock Protein Family A (Hsp70) Member 5 GAPDHGlyceraldehyde-3-Phosphate Dehydrogenase
PHKA2Phosphorylase Kinase Regulatory Subunit Alpha 2 IGFN1Immunoglobulin Like And Fibronectin Type III Domain Containing 1 GPX3Glutathione Peroxidase 3
PLA2G7Phospholipase A2 Group VII INF2Inverted Formin 2 GSNAngiotensin I Converting Enzyme 2
PORCytochrome P450 Oxidoreductase L3MBTL4L3MBTL Histone Methyl-Lysine Binding Protein 4 H2BC1H2B Clustered Histone 1
RANBP17RAN Binding Protein 17 LMNB1Lamin B1 H2BC11H2B Clustered Histone 11
RGS22Regulator Of G Protein Signaling 22 LMNB2Lamin B2 H2BC12H2B Clustered Histone 12
RIF1Replication Timing Regulatory Factor 1 MFAP5Microfibril Associated Protein 5 H2BC13H2B Clustered Histone 13
RTN4Reticulon 4 MRPL50Mitochondrial Ribosomal Protein L50 H2BC14H2B Clustered Histone 14
SARS2Seryl-TRNA Synthetase 2, Mitochondrial MS4A6AMembrane Spanning 4-Domains A6A H2BC15H2B Clustered Histone 15
SEPHS2Selenophosphate Synthetase 2 MUC4Mucin 4, Cell Surface Associated H2BC17H2B Clustered Histone 17
SLFN13Schlafen Family Member 13 MYH14Myosin Heavy Chain 14 H2BC18H2B Clustered Histone 18
SLKSTE20 Like Kinase MYL6BMyosin Light Chain 6B H2BC21H2B Clustered Histone 21
SPATA20Spermatogenesis Associated 20 NEK10NIMA Related Kinase 10 H2BC3H2B Clustered Histone 3
SPATA5Spermatogenesis Associated 5 PAK3P21 (RAC1) Activated Kinase 3 H2BC5H2B Clustered Histone 5
SPTA1Spectrin Alpha, Erythrocytic 1 PAPOLAPoly(A) Polymerase Alpha H2BC9H2B Clustered Histone 9
SQLESqualene Epoxidase PAPOLGPoly(A) Polymerase Gamma H2BS1H2B.S Histone 1
ST20-AS1ST20 Antisense RNA 1 PDIA3Protein Disulfide Isomerase Family A Member 3 H2BU1H2B.U Histone 1
STILSTIL Centriolar Assembly Protein PDLIM4PDZ And LIM Domain 4 HBA1Hemoglobin Subunit Alpha 1
TACC2Transforming Acidic Coiled-Coil Containing Protein 2 RALBP1RalA Binding Protein 1 HBA2Hemoglobin Subunit Alpha 2
TAP1Transporter 1, ATP Binding Cassette Subfamily B Member RNF213Ring Finger Protein 213 HBBHemoglobin Subunit Beta
THADATHADA Armadillo Repeat Containing SBF2SET Binding Factor 2 HBDHemoglobin Subunit Delta
THBS3Thrombospondin 3 SERPINF1Serpin Family F Member 1 HBE1Hemoglobin Subunit Epsilon 1
UQCRC1Ubiquinol-Cytochrome C Reductase Core Protein 1 SERPINH1Serpin Family H Member 1 HBG1Hemoglobin Subunit Gamma 1
VWA3AVon Willebrand Factor A Domain Containing 3A SLC4A5Solute Carrier Family 4 Member 5 HBG2Hemoglobin Subunit Gamma 2
ZNF333Zinc Finger Protein 333 SLIT2Slit Guidance Ligand 2 HBZHemoglobin Subunit Zeta
SMPD3Sphingomyelin Phosphodiesterase 3 HPHaptoglobin
TAPT1Transmembrane Anterior Posterior Transformation 1 HPRHaptoglobin-Related Protein
TBX22T-Box Transcription Factor 22 HSPB1Heat Shock Protein Family B (Small) Member 1
TDRD1Tudor Domain Containing 1 IGHA1Immunoglobulin Heavy Constant Alpha 1
TENM4Teneurin Transmembrane Protein 4 IGHA2Immunoglobulin Heavy Constant Alpha 2 (A2m Marker)
THBS1Thrombospondin 1 IGHG1Immunoglobulin Heavy Constant Gamma 1 (G1m Marker)
TJP2Tight Junction Protein 2 IGHG2Immunoglobulin Heavy Constant Gamma 2 (G2m Marker)
TTRTransthyretin IGHG3Immunoglobulin Heavy Constant Gamma 3 (G3m Marker)
UBP1Upstream Binding Protein 1 IGHG4Immunoglobulin Heavy Constant Gamma 4 (G4m Marker)
WHRNWhirlin IGKCImmunoglobulin Kappa Constant
ZNF155Zinc Finger Protein 155 INAInternexin Neuronal Intermediate Filament Protein Alpha
ZNF221Zinc Finger Protein 221 KRT7Keratin 7
KRT8Keratin 8
KRT84Keratin 84
LGALS1Galectin 1
LMNALamin A/C
LUMLumican
MFAP4Microfibril Associated Protein 4
MFGE8Milk Fat Globule EGF And Factor V/VIII Domain Containing
MYH16Myosin Heavy Chain 16 Pseudogene
MYOCMyocilin
NEFHNeurofilament Heavy
NEFLNeurofilament Light
NEFMNeurofilament Medium
OGNOsteoglycin
POTEEPOTE Ankyrin Domain Family Member E
POTEFPOTE Ankyrin Domain Family Member F
POTEIPOTE Ankyrin Domain Family Member I
POTEJPOTE Ankyrin Domain Family Member J
POTEKPPOTE Ankyrin Domain Family Member K, Pseudogene
PPIAPeptidylprolyl Isomerase A
PRDX1Peroxiredoxin 1
PRDX2Peroxiredoxin 2
PRELPProline And Arginine Rich End Leucine Rich Repeat Protein
PRPHPeripherin
RPL7L1Ribosomal Protein L7 Like 1
S100A10S100 Calcium Binding Protein A10
SALL3Spalt Like Transcription Factor 3
SERPINA1Serpin Family A Member
SHLD3Shieldin Complex Subunit 3
SLC4A1Solute Carrier Family 4 Member 1
SOD3Superoxide Dismutase 3
TFTransferrin
TGFBITransforming Growth Factor Beta Induced
THBS4Thrombospondin 4
TNCTenascin C
TNXATenascin XA (Pseudogene)
TNXBTenascin XB
TUBA1ATubulin Alpha 1a
TUBA1BTubulin Alpha 1b
TUBA1CTubulin Alpha 1c
TUBA3ETubulin Alpha 3e
TUBA4ATubulin Alpha 4a
TUBA8Tubulin Alpha 8
TUBBTubulin Beta Class I
TUBB1Tubulin Beta 1 Class VI
TUBB2ATubulin Beta 2A Class IIa
TUBB2BTubulin Beta 2B Class IIb
TUBB3Tubulin Beta 3 Class III
TUBB4ATubulin Beta 4A Class IVa
TUBB4BTubulin Beta 4B Class IVb
TUBB6Tubulin Beta 6 Class V
TUBB8Tubulin Beta 8 Class VIII
TUBB8BTubulin Beta 8B
Table 4. Proteins expressed in both synovial fluid and TMJ disc samples of each group.
Table 4. Proteins expressed in both synovial fluid and TMJ disc samples of each group.
Protein Expressed in Each Group of TMJ Synovial Fluid and Disc Samples (n = 11)
DDWoR (n= 2)MD (n = 3)CH (n = 0)DDWoR and MD (n = 0)DDWoR and CH (n = 0)MD and CH (n = 0)DDWoR, MD and CH (n = 6)
CHD8FLNA ENO1
MYL6BPPFIA1 ENO2
PPFIA2 ENO3
MYH16
RPL7L1
SHLD3
Table 5. Gene code, protein name and function for each sample of TMJ synovial fluid.
Table 5. Gene code, protein name and function for each sample of TMJ synovial fluid.
Synovial Fluid Sample
CodeNameFunction
DDWoR
A2MAlpha-2-MacroglobulinInhibits inflammatory cytokines.
APCSAmyloid P Component, SerumBinds to apoptotic cells at an early stage.
GPSM2G Protein Signaling Modulator 2Involved in the development of normal hearing.
KRT18Keratin 18 Is involved in interleukin-6-mediated barrier protection.
MAP3K7Mitogen-Activated Protein Kinase Kinase Kinase 7Mediates signal transduction various cytokines including interleukin-1, transforming growth factor-beta, bone morphogenetic protein 2 and 4, Toll-like receptors, tumor necrosis factor receptor CD40 and B-cell receptor.
SERPINC1Serpin Family C Member 1This protein inhibits thrombin and it regulates the blood coagulation cascade.
MD
ALDH1L1Aldehyde Dehydrogenase 1 Family Member L1Associated with decreased apoptosis, increased cell motility, and cancer progression.
C4AComplement C4A (Rodgers Blood Group) An antimicrobial peptide and a mediator of local inflammation.
HPXHemopexinAcute phase protein that transports heme from the plasma to the liver and may be involved in protecting cells from oxidative stress.
IFT122Intraflagellar Transport 122 Involved in cell cycle progression, signal transduction, apoptosis, and gene regulation.
MYO6Myosin VIThis protein maintains the structural integrity of inner ear hair cells and mutations in this gene cause hearing loss.
PRDX1Peroxiredoxin 1 Has an antioxidant protective role in cells and may contribute to the antiviral activity of CD8(+) T-cells.
SERPINH1Serpin Family H Member 1 Plays a role in collagen biosynthesis as a collagen-specific molecular chaperone.
SMPD3Sphingomyelin Phosphodiesterase 3Mediates cellular functions, such as apoptosis and growth arrest.
CH
ADH1Alcohol Dehydrogenase Subunit AlphaCatalyzes the oxidation of alcohols to aldehydes.
DDWoR and MD
ANXA1Annexin A1Inhibits phospholipase A2 and has anti-inflammatory activity.
ANXA2Annexin A2Functions as an autocrine factor which heightens osteoclast formation and bone resorption.
ASPNAsporinRegulate chondrogenesis by inhibiting transforming growth factor-beta 1-induced gene expression in cartilage. May induce collagen mineralization.
BGNBiglycanPlays a role in bone growth, muscle development and regeneration, and collagen fibril assembly in multiple tissues. This protein may also regulate inflammation and innate immunity.
CILPCartilage Intermediate Layer ProteinThis protein is present in the cartilage intermediate layer protein (CILP), which increases in early osteoarthrosis cartilage.
CLUClusterinUnder stress conditions can be found in the cell cytosol. May be involved in cell death, tumor progression, and neurodegenerative disorders
COMPThrombospondin-5Present in rheumatoid arthritis, is a noncollagenous extracellular matrix protein.
DCNDecorinHas a stimulatory effect on autophagy and inflammation and an inhibitory effect on angiogenesis and tumorigenesis.
FMODFibromodulinMay also regulate TGF-beta activities by sequestering TGF-beta into the extracellular matrix.
FN1Fibronectin 1Fibronectin is involved in cell adhesion and migration processes including embryogenesis, wound healing, blood coagulation, host defense.
IGHG1Immunoglobulin Heavy Constant Gamma 1 (G1m Marker)Involved in pathways of Interleukin-4 and 13 signaling and IL4-mediated signaling events.
DDWoR and CH
xxx
MD and CH
xxx
DDWoR, MD and CH
ENO2Enolase 2Found in mature neurons and cells of neuronal origin.
ENO3Enolase 3May play a role in muscle development and regeneration.
Table 6. Gene code, protein name and function for each sample of TMJ discs.
Table 6. Gene code, protein name and function for each sample of TMJ discs.
Disc Sample
CodeNameFunction
DDWoR
AMBPAlpha-1-Microglobulin/Bikunin PrecursorRegulation of the inflammatory process.
MMP10Matrix Metallopeptidase 10Breakdown of extracellular matrix.
MMP27Matrix Metallopeptidase 27Breakdown of extracellular matrix.
MMP3Matrix Metallopeptidase 3Breakdown of extracellular matrix.
PLA2G7Phospholipase A2 Group VIIInflammatory and oxidative stress response.
THADATHADA Armadillo Repeat ContainingApoptosis pathway.
THBS3Thrombospondin 3Matrix interactions.
MD
AKAP13A-kinase anchor protein 13Regulation of apoptotic process.
CCDC88AGirdinVascular endothelial growth factor receptor 2 binding.
COL4A1Collagen alpha-1(IV) chainExtracellular matrix structural constituent.
ERASGTPase ERasTumor-like growth properties of embryonic stem cells.
ERBINErbinInhibits NOD2-dependent NF-kappa-B signaling and proinflammatory cytokine secretion.
PARP10Protein mono-ADP-ribosyltransferase PARP10Negative regulation of fibroblast proliferation.
PPFIA1Liprin-alpha-1Cell–matrix adhesion.
PPFIA2Liprin-alpha-2Cell–matrix adhesion.
PTPN7Tyrosine-protein phosphatase non-receptor type 7Regulation of T and B-lymphocyte development and signal transduction.
UPK3AUroplakin-3aEpithelial cell differentiation.
CH
ACTN4Actinin Alpha 4Transcriptional coactivator.
ADAM10ADAM Metallopeptidase Domain 10Responsible for the FasL ectodomain shedding.
COQ8BCoenzyme Q8BBiosynthesis of coenzyme Q.
HPXHemopexinProtect cells from oxidative stress.
HSPA1AHeat Shock Protein Family A (Hsp70) Member 1A Protection of the proteome from stress.
NEK10NIMA Related Kinase 10Cellular response to UV irradiation.
PDLIM4PDZ And LIM Domain 4Involved in bone development.
SERPINH1Serpin Family H Member 1 Chaperone in the biosynthetic pathway of collagen.
TTRTransthyretinThyroid hormone-binding protein.
COL1A2Collagen Type I Alpha 2 Chain Fibril-forming collagen abundant in bone.
PRG4Proteoglycan 4This protein contains both chondroitin sulfate and keratan sulfate glycosaminoglycans.
PTPN13Protein Tyrosine Phosphatase Non-Receptor Type 13Regulates negatively FasL induced apoptosis.
DDWoR and MD
C4AComplement C4AAntimicrobial peptide and a mediator of local inflammation.
C4BComplement C4BMediator of local inflammation.
C4B_2Complement Component 4BMediator of local inflammatory process.
SEMA4FSemaphorin 4FPlays a role in neural development.
CodeNameFunction
DDWoR and CH
ACANAggrecanPart of the extracellular matrix that withstands compression in cartilage.
COL1A1Collagen Type I Alpha 1 ChainCollagen component.
COL4A6Collagen Type IV Alpha 6 Chain Major structural component of basement membranes.
HSPA2Heat Shock Protein Family A (Hsp70) Member 2Protection of the proteome from stress.
POSTNPeriostinExtracellular matrix protein that functions in tissue development and regeneration, including wound healing.
MD and CH
KRT6AKeratin 6AEpidermis-specific type I keratin involved in wound healing.
DDWoR, MD and CH
ANXA1Annexin A1Anti-inflammatory activity.
ANXA2Annexin A2Heightens osteoclast formation and bone resorption.
ANXA2P2Annexin A2 Pseudogene 2May be involved in heat-stress response.
APCSAmyloid P ComponentIs involved in dealing with apoptotic cells in vivo.
ASPNAsporinRegulates chondrogenesis by inhibiting transforming growth factor-beta 1-induced gene expression in cartilage
BGNBiglycan Plays a role in bone growth, and collagen fibril assembly in multiple tissues. This protein may also regulate inflammation and innate immunity.
C3Complement C3 Modulates inflammation and possesses antimicrobial activity.
CILPCartilage Intermediate Layer ProteinIncreases in early osteoarthrosis cartilage.
COL12A1Collagen Type XII Alpha 1 ChainType XII collagen.
COL14A1Collagen Type XIV Alpha 1 ChainType XIV collagen.
COL6A1Collagen Type VI Alpha 1 ChainCollagen VI.
COL6A2Collagen Type VI Alpha 2 Chain Type VI collagen.
COL6A3Collagen Type VI Alpha 3 ChainTtype VI collagen.
COMPCartilage Oligomeric Matrix ProteinDegradation of the extracellular matrix.
ENO1Enolase 1Tumor suppressor.
ENO2Enolase 2Found in mature neurons and cells of neuronal origin.
ENO3Enolase 3Plays a role in muscle development and regeneration.
FN1Fibronectin 1Involved in wound healing, blood coagulation, host defense.
KRT7Keratin 7Co-expressed during differentiation of simple and stratified epithelial tissues.
LUMLumican May regulate collagen fibril organization, epithelial cell migration and tissue repair.
MFAP4Microfibril Associated Protein 4Extracellular matrix protein which is involved in cell adhesion or intercellular interactions.
MFGE8Milk Fat Globule EGF And Factor V/VIII Domain ContainingPromotes phagocytosis of apoptotic cells. This protein has also been implicated in wound healing, autoimmune disease, and cancer.
OGNOsteoglycinInduces ectopic bone formation in conjunction with transforming growth factor beta and may regulate osteoblast differentiation.
SOD3Superoxide Dismutase 3Antioxidant enzymes that protect tissues from oxidative stress.
TGFBITransforming Growth Factor Beta InducedMay be involved in endochondrial bone formation in cartilage.
TNCTenascin C Modulation of inflammatory cytokine.
TNXBTenascin XB Accelerates collagen fibril formation.
VCANVersicanA large chondroitin sulfate proteoglycan and is a major component of the extracellular matrix.
VIMVimentin Involved in the stabilization of type I collagen mRNAs for CO1A1 and CO1A2.
Table 7. Name and function of expressed proteins in common between synovial fluid and TMJ disc sample, and the groups in each protein was expressed.
Table 7. Name and function of expressed proteins in common between synovial fluid and TMJ disc sample, and the groups in each protein was expressed.
NameFunctionDiscSynovial Fluid
Amyloid P Component, SerumIs involved in dealing with apoptotic cells in vivo.DDWoR, MD and CHDDWoR
Annexin A1Anti-inflammatory activity.DDWoR, MD and CHDDWoR and MD
Annexin A2Heightens osteoclast formation and bone resorption.DDWoR, MD and CHDDWoR and MD
AsporinRegulates chondrogenesis.DDWoR, MD and CHDDWoR and MD
BiglycanPlays a role in bone growth, and collagen fibril assembly in multiple tissues.DDWoR, MD and CHDDWoR and MD
Cartilage Intermediate Layer ProteinIncreases in early osteoarthrosis cartilage.DDWoR, MD and CHDDWoR and MD
Complement C4A Antimicrobial peptide and a mediator of local inflammation.DDWoR and MDMD
Enolase 2Found in mature neurons and cells of neuronal origin.DDWoR, MD and CHDDWoR, MD and CH
Enolase 3Play a role in muscle development and regeneration.DDWoR, MD and CHDDWoR, MD and CH
Fibronectin 1Involved in wound healing, blood coagulation, host defense.DDWoR, MD and CHDDWoR and MD
HemopexinProtect cells from oxidative stress.CHMD
LumicanMay regulate collagen fibril organization, epithelial cell migration and tissue repair.DDWoR, MD and CHDDWoR and MD
Osteoglycin Regulate osteoblast differentiation.DDWoR, MD and CHDDWoR and MD
Serpin Family H Member 1 Chaperones in the biosynthetic pathway of collagen.CHMD
Superoxide Dismutase 3 Antioxidant enzymes that protect tissues from oxidative stress.DDWoR, MD and CHDDWoR and MD
Tenascin XBModulation of inflammatory cytokine.DDWoR, MD and CHDDWoR and MD
Transforming Growth Factor Beta InducedMay be involved in endochondral bone formation in cartilage.DDWoR, MD and CHDDWoR and MD
Versican A large chondroitin sulfate proteoglycan and is a major component of the extracellular matrix.DDWoR, MD and CHDDWoR and MD
Table 8. Types of collagen identified in each TMJ disc group.
Table 8. Types of collagen identified in each TMJ disc group.
Type of Collagen Identified in Each Group
DDWoRMDCHDDWoR and MDDDWoR and CHMD and CHDDWoR, MD and CH
xCodeNameCodeNamexCodeNamexCodeName
COL4A1Collagen Type IV Alpha 1 ChainCOL1A2Collagen Type I Alpha 2 Chain COL1A1Collagen Type I Alpha 1 Chain COL12A1Collagen Type XII Alpha 1 Chain
COL4A6Collagen Type IV Alpha 6 Chain COL14A1Collagen Type XIV Alpha 1 Chain
COL6A1Collagen Type VI Alpha 1 Chain
COL6A2Collagen Type VI Alpha 2 Chain
COL6A3Collagen Type VI Alpha 3 Chain
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Doetzer, A.D.; Herai, R.H.; Buzalaf, M.A.R.; Trevilatto, P.C. Proteomic Expression Profile in Human Temporomandibular Joint Dysfunction. Diagnostics 2021, 11, 601. https://doi.org/10.3390/diagnostics11040601

AMA Style

Doetzer AD, Herai RH, Buzalaf MAR, Trevilatto PC. Proteomic Expression Profile in Human Temporomandibular Joint Dysfunction. Diagnostics. 2021; 11(4):601. https://doi.org/10.3390/diagnostics11040601

Chicago/Turabian Style

Doetzer, Andrea Duarte, Roberto Hirochi Herai, Marília Afonso Rabelo Buzalaf, and Paula Cristina Trevilatto. 2021. "Proteomic Expression Profile in Human Temporomandibular Joint Dysfunction" Diagnostics 11, no. 4: 601. https://doi.org/10.3390/diagnostics11040601

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop